Furthermore, the distinct tumor microenvironment between the HDTVI delivery of YAP1 and non-invasive TET-ON YAP1 expression in HC used for the YAP1-alone liver cancer model, along with the collaboration of constitutive active AKT, needs to be carefully compared to conclude these different observations. The gene discussed is AKT1; the disease is liver cancer.